Skip to content

LONA LONA Investing Cash Flow

Investing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$3.92B-16.8%
Arvinas logo
ArvinasARVN
$13.7M-80.3%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$4.53M+110%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$54.9M+84.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0+100%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$243.83M-812%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's investing cash flow?
LONA (LONA) reported investing cash flow of -$15.54M in Q1 2026.
How has LONA's investing cash flow changed year-over-year?
LONA's investing cash flow decreased by 111.4% year-over-year, from -$7.35M to -$15.54M.
What is the long-term trend for LONA's investing cash flow?
Over 2 years (2022 to 2024), LONA's investing cash flow has grown at a -3.7% compound annual growth rate (CAGR), from $62.13M to $57.64M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.